Atagunduz, I. K. Et Al. 2017. THE FREQUENCY AND CLINICAL SIGNIFICANCE OF MEFV GENE MUTATIONS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA. 22nd Congress of the European-Hematology-Association , (Madrid, Spain), 590-591.

Atagunduz, I. K., Keklikkiran, C., Toptas, T., Kara, O., Sezgin, A., Gecgel, F., ... Ozgumus, T.(2017). THE FREQUENCY AND CLINICAL SIGNIFICANCE OF MEFV GENE MUTATIONS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA . 22nd Congress of the European-Hematology-Association (pp.590-591). Madrid, Spain

Atagunduz, IŞIK Et Al. "THE FREQUENCY AND CLINICAL SIGNIFICANCE OF MEFV GENE MUTATIONS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA," 22nd Congress of the European-Hematology-Association, Madrid, Spain, 2017

Atagunduz, IŞIK Et Al. "THE FREQUENCY AND CLINICAL SIGNIFICANCE OF MEFV GENE MUTATIONS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA." 22nd Congress of the European-Hematology-Association , Madrid, Spain, pp.590-591, 2017

Atagunduz, I. K. Et Al. (2017) . "THE FREQUENCY AND CLINICAL SIGNIFICANCE OF MEFV GENE MUTATIONS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA." 22nd Congress of the European-Hematology-Association , Madrid, Spain, pp.590-591.

@conferencepaper{conferencepaper, author={IŞIK ATAGÜNDÜZ Et Al. }, title={THE FREQUENCY AND CLINICAL SIGNIFICANCE OF MEFV GENE MUTATIONS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA}, congress name={22nd Congress of the European-Hematology-Association}, city={Madrid}, country={Spain}, year={2017}, pages={590-591} }